<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Jon Ogg - Seeking Alpha</title>
    <description>'Jon Ogg' Tag RSS Syndication from SeekingAlpha.com</description>
    <author>
      <name>SeekingAlpha.com</name>
    </author>
    <link>http://seekingalpha.com/author/jon-ogg</link>
    <item>
      <title>Why Vail Banks Was a Steal For US Bancorp (VAIL, USB)</title>
      <link>http://seekingalpha.com/article/11504-why-vail-banks-was-a-steal-for-us-bancorp-vail-usb?source=feed</link>
      <guid isPermaLink="false">11504</guid>
      <content>
        <![CDATA[This morning the inevitable finally occurred. Vail Banks (VAIL) finally got a buyout offer. The price is a steal for US Bancorp (USB). Terms of the agreement include a total cash purchase price of approximately $98.6 million, or $17.00 for each share of Vail Banks, Inc. common stock, which represents a premium to core deposits of 13.7 percent (according to the press release) and a 6% premium to yesterday's close.
</p>
<p>Vail Banks, Inc., headquartered in Avon, Colorado, had consolidated assets of $705 million and $557 million in deposits, as of March 31, 2006. This company operates as the parent and holding company of WestStar Bank that operates 25 banking offices and 20 ATMs in 18 communities throughout Colorado. 
</p>]]>
      </content>
      <pubDate>Thu, 01 Jun 2006 11:26:55 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[This morning the inevitable finally occurred. Vail Banks (VAIL) finally got a buyout offer. The price is a steal for US Bancorp (USB). Terms of the agreement include a total cash purchase price of approximately $98.6 million, or $17.00 for each share of Vail Banks, Inc. common stock, which represents a premium to core deposits of 13.7 percent (according to the press release) and a 6% premium to yesterday's close.
</p>
<p>Vail Banks, Inc., headquartered in Avon, Colorado, had consolidated assets of $705 million and $557 million in deposits, as of March 31, 2006. This company operates as the parent and holding company of WestStar Bank that operates 25 banking offices and 20 ATMs in 18 communities throughout Colorado. 
</p><br/><a href='http://seekingalpha.com/article/11504-why-vail-banks-was-a-steal-for-us-bancorp-vail-usb?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/usb">USB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/vail">VAIL</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>IPO Preview: Russia's CTC Media Prices Tonight (CTCM)</title>
      <link>http://seekingalpha.com/article/11439-ipo-preview-russia-s-ctc-media-prices-tonight-ctcm?source=feed</link>
      <guid isPermaLink="false">11439</guid>
      <content>
        <![CDATA[Tonight we are set to get a pricing of the CTC Media (CTCM) IPO, a Russian television network operator. The company broadcasts directly over the airwaves and directly by satellite and has also expanded its reach nationally by launching its own CTC network rated #4 in Russia according to reports.<!--more-->
</p>
<p>Lead underwriters are Morgan Stanley and Deutsche Bank, with J.P.Morgan as the Co-Manager. The current plans are for 29.4 million shares at a proposed range of $16.00 to $18.00 per share, giving CTC Media a potential market value of $2.75 billion depending on price.
</p>]]>
      </content>
      <pubDate>Wed, 31 May 2006 14:11:50 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[Tonight we are set to get a pricing of the CTC Media (CTCM) IPO, a Russian television network operator. The company broadcasts directly over the airwaves and directly by satellite and has also expanded its reach nationally by launching its own CTC network rated #4 in Russia according to reports.<!--more-->
</p>
<p>Lead underwriters are Morgan Stanley and Deutsche Bank, with J.P.Morgan as the Co-Manager. The current plans are for 29.4 million shares at a proposed range of $16.00 to $18.00 per share, giving CTC Media a potential market value of $2.75 billion depending on price.
</p><br/><a href='http://seekingalpha.com/article/11439-ipo-preview-russia-s-ctc-media-prices-tonight-ctcm?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/ctcm">CTCM</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Monday Pre-Market Notes By Stock Ticker</title>
      <link>http://seekingalpha.com/article/11122-monday-pre-market-notes-by-stock-ticker?source=feed</link>
      <guid isPermaLink="false">11122</guid>
      <content>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong>
</p>
<p>Yesterdays Closing Levels:
<br />
DJIA 11,125.33 (-18.73; -0.17%)
<br />
NASDAQ 2,172.86 (-21.03; -0.96%)
<br />
S&P500 1,262.07 (-4.96; -0.39%)
<br />
S&P FAIR VALUE PRE-MARKET +$3.12.
</p>]]>
      </content>
      <pubDate>Tue, 23 May 2006 09:15:17 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong>
</p>
<p>Yesterdays Closing Levels:
<br />
DJIA 11,125.33 (-18.73; -0.17%)
<br />
NASDAQ 2,172.86 (-21.03; -0.96%)
<br />
S&P500 1,262.07 (-4.96; -0.39%)
<br />
S&P FAIR VALUE PRE-MARKET +$3.12.
</p><br/><a href='http://seekingalpha.com/article/11122-monday-pre-market-notes-by-stock-ticker?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Monday Pre-Market Notes By Ticker</title>
      <link>http://seekingalpha.com/article/11056-monday-pre-market-notes-by-ticker?source=feed</link>
      <guid isPermaLink="false">11056</guid>
      <content>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong>
</p>
<p>S&P FAIR VALUE -$0.52.  US Stock futures indicated down 0.6% after additional selling in EU & Asia.
</p>]]>
      </content>
      <pubDate>Mon, 22 May 2006 09:01:47 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong>
</p>
<p>S&P FAIR VALUE -$0.52.  US Stock futures indicated down 0.6% after additional selling in EU & Asia.
</p><br/><a href='http://seekingalpha.com/article/11056-monday-pre-market-notes-by-ticker?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>MasterCard and Vonage IPOs: Quick Previews (MA, VG)</title>
      <link>http://seekingalpha.com/article/10995-mastercard-and-vonage-ipos-quick-previews-ma-vg?source=feed</link>
      <guid isPermaLink="false">10995</guid>
      <content>
        <![CDATA[This week we have two major IPO's coming to market.  One is MasterCard and one is Vonage.  There is strong demand so far for both companies as both are said to be oversubscribed, and our recommendation for the other four of five companies on the IPO docket next week is this: "Come public on a different day than both MasterCard and Vonage if you want any free publicity that day."

<p><img src="http://static.seekingalpha.com/wp-content/seekingalpha/images/mclogo.gif" vspace="6" border="0" height="56" hspace="6" align="left" width="93" /> Master Card (MA) has scheduled a 61.5+ million share IPO with a range of $40.00 to $43.00, with a pricing set for Wednesday night and trading Thursday.  MasterCard is of course one of the leading providers of credit and debit card services for thousands of financial institutions and name guarantor of the credit cards under the same name.  According to all discussions it looks the only thing that may prevent this coming in at the high-end of the range (or above) or with a higher number of shares is a serious market slide between now and the IPO date.  
</p>
<p>The underwriting group is massive: Goldman Sachs is the Lead Manager; Joint Book-Runners are Citigroup, HSBC, J.P.Morgan; and the co-managers are Bear Stearns, Cowen & Co., Deutsche Bank, Harris Nesbitt, KeyBanc Capital, and Santander Investment.  The IPO will raise over $2.4 Billion and the implied market cap will be right at $5.6 Billion.  
</p>]]>
      </content>
      <pubDate>Sun, 21 May 2006 07:28:23 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[This week we have two major IPO's coming to market.  One is MasterCard and one is Vonage.  There is strong demand so far for both companies as both are said to be oversubscribed, and our recommendation for the other four of five companies on the IPO docket next week is this: "Come public on a different day than both MasterCard and Vonage if you want any free publicity that day."

<p><img src="http://static.seekingalpha.com/wp-content/seekingalpha/images/mclogo.gif" vspace="6" border="0" height="56" hspace="6" align="left" width="93" /> Master Card (MA) has scheduled a 61.5+ million share IPO with a range of $40.00 to $43.00, with a pricing set for Wednesday night and trading Thursday.  MasterCard is of course one of the leading providers of credit and debit card services for thousands of financial institutions and name guarantor of the credit cards under the same name.  According to all discussions it looks the only thing that may prevent this coming in at the high-end of the range (or above) or with a higher number of shares is a serious market slide between now and the IPO date.  
</p>
<p>The underwriting group is massive: Goldman Sachs is the Lead Manager; Joint Book-Runners are Citigroup, HSBC, J.P.Morgan; and the co-managers are Bear Stearns, Cowen & Co., Deutsche Bank, Harris Nesbitt, KeyBanc Capital, and Santander Investment.  The IPO will raise over $2.4 Billion and the implied market cap will be right at $5.6 Billion.  
</p><br/><a href='http://seekingalpha.com/article/10995-mastercard-and-vonage-ipos-quick-previews-ma-vg?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/ma">MA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/vg">VG</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Burger King IPO: Demand Moderate (BKC)</title>
      <link>http://seekingalpha.com/article/10886-burger-king-ipo-demand-moderate-bkc?source=feed</link>
      <guid isPermaLink="false">10886</guid>
      <content>
        <![CDATA[Burger King (BKC) did price its 25M share IPO at $17.00, which was at the high-end of the $15.00 to $17.00 range.  J.P. Morgan was the Lead Manager and co-managers were Citigroup, Goldman Sachs, Morgan Stanley, Wachovia Securities, Bear Stearns, Credit Suisse, Lehman Brothers, and Loop Capital Markets.  <!--more-->The details of this have already been covered, but the company has the following metrics: almost 90% of the 11,000 restaurants are franchises, although that number varies from source to source; the company's Fiscal Year June 2005 revenues were $1.94 Billion with net income of $47 Million.
</p>
<p>The company was purchased by private equity firms Texas Pacific Group, Bain Capital and Goldman Sachs Capital Partners -- unit of Goldman Sachs (GS) -- which bought Burger King in 2002 for $1.5 billion after a period of slumping sales.  At the $17.00 pricing, it looks like the implied market cap of approximately $2.3 Billion, and an enterprise value with the debt of approximately $3.5 Billion.  At the offering this represents about 19% of the shares being in the free float (see implications below).
</p>]]>
      </content>
      <pubDate>Thu, 18 May 2006 10:38:21 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[Burger King (BKC) did price its 25M share IPO at $17.00, which was at the high-end of the $15.00 to $17.00 range.  J.P. Morgan was the Lead Manager and co-managers were Citigroup, Goldman Sachs, Morgan Stanley, Wachovia Securities, Bear Stearns, Credit Suisse, Lehman Brothers, and Loop Capital Markets.  <!--more-->The details of this have already been covered, but the company has the following metrics: almost 90% of the 11,000 restaurants are franchises, although that number varies from source to source; the company's Fiscal Year June 2005 revenues were $1.94 Billion with net income of $47 Million.
</p>
<p>The company was purchased by private equity firms Texas Pacific Group, Bain Capital and Goldman Sachs Capital Partners -- unit of Goldman Sachs (GS) -- which bought Burger King in 2002 for $1.5 billion after a period of slumping sales.  At the $17.00 pricing, it looks like the implied market cap of approximately $2.3 Billion, and an enterprise value with the debt of approximately $3.5 Billion.  At the offering this represents about 19% of the shares being in the free float (see implications below).
</p><br/><a href='http://seekingalpha.com/article/10886-burger-king-ipo-demand-moderate-bkc?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/bkc">BKC</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Neurocrine's Implosion: Let The Dust Settle Before Buying (NBIX)</title>
      <link>http://seekingalpha.com/article/10791-neurocrine-s-implosion-let-the-dust-settle-before-buying-nbix?source=feed</link>
      <guid isPermaLink="false">10791</guid>
      <content>
        <![CDATA[After the overwhelming traffic generated from the <a href="http://biotechstockblog.com/article/10733">“Evaluating the Implosion in Neurocrine”</a> article, it is worth providing some additional data that still offer patience as the best guide rather than trying to be brave and fighting the tape.  Neurocrine Biosciences (NBIX) is trading down another 4.8% pre-market and has cracked under the $20 mark.  
<br />
<!--more-->
<br />
As noted in yesterday’s article, it is almost always better to patient on biotech implosions than it is to be brave and that is still the case.  There should be some value left in the company after the dust settles, but in cases like these implosions you have to exercise caution and patience.  It is also impossible to know yet where the value will be ($20, $15, $10, $5, etc...) ahead of time.  After you see a stock lose 48%, 52% and then over 60% it is of little consequence if you have to pay up a little for it days or weeks later, even if it has recovered 10% or 20% off the lows.  What is important is to let the dust settle and evaluate the situation when you have a very clear idea of what the picture looks like and when you can evaluate the merits in finite terms and figures. 
</p>
<p>Also as noted yesterday, when you see these implosions the balance sheet and revenue statements can be very misleading because the entire equation changes and you just do not know what the real picture will look like.  After we find out what the financial terms are and what certain covenants are, then it is possible to form a longer-term opinion; but once again, when dealing with biotech implosions patience is usually better than trying to be brave.  
</p>]]>
      </content>
      <pubDate>Wed, 17 May 2006 09:57:33 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[After the overwhelming traffic generated from the <a href="http://biotechstockblog.com/article/10733">“Evaluating the Implosion in Neurocrine”</a> article, it is worth providing some additional data that still offer patience as the best guide rather than trying to be brave and fighting the tape.  Neurocrine Biosciences (NBIX) is trading down another 4.8% pre-market and has cracked under the $20 mark.  
<br />
<!--more-->
<br />
As noted in yesterday’s article, it is almost always better to patient on biotech implosions than it is to be brave and that is still the case.  There should be some value left in the company after the dust settles, but in cases like these implosions you have to exercise caution and patience.  It is also impossible to know yet where the value will be ($20, $15, $10, $5, etc...) ahead of time.  After you see a stock lose 48%, 52% and then over 60% it is of little consequence if you have to pay up a little for it days or weeks later, even if it has recovered 10% or 20% off the lows.  What is important is to let the dust settle and evaluate the situation when you have a very clear idea of what the picture looks like and when you can evaluate the merits in finite terms and figures. 
</p>
<p>Also as noted yesterday, when you see these implosions the balance sheet and revenue statements can be very misleading because the entire equation changes and you just do not know what the real picture will look like.  After we find out what the financial terms are and what certain covenants are, then it is possible to form a longer-term opinion; but once again, when dealing with biotech implosions patience is usually better than trying to be brave.  
</p><br/><a href='http://seekingalpha.com/article/10791-neurocrine-s-implosion-let-the-dust-settle-before-buying-nbix?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/nbix">NBIX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nktr">NKTR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/qsc">QSC</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Wednesday Pre-Market Notes By Stock Ticker</title>
      <link>http://seekingalpha.com/article/10790-wednesday-pre-market-notes-by-stock-ticker?source=feed</link>
      <guid isPermaLink="false">10790</guid>
      <content>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong>
</p>
<p>S&P Fair Value +$1.03.
</p>
<p>(AMAT) Applied Materials $0.29 EPS vs $0.23e; R$2.25B vs $2.15B(e);new orders $2.49B; stock trading down 1.8% pre-market.
<br />
(ANF) Abercrombie & Fitch $0.62 EPS vs $0.54e.
<br />
(AZN) AstraZeneca NXY-059 is safe in stroke studies and will seek FDA approval in 2007.
<br />
(BIDU) Baidu.com up 1% on hard disk search pact with IBM.
<br />
(CD) Cendant’s travel business are reportedly being looked at by private equity firms.
<br />
(CHRS) Charming Shoppes $0.24 EPS vs $0.24e.
<br />
(CPWR) Compuware $0.15 EPS vs $0.13e; R$309.48M vs $309.9M(e).
<br />
(CYB) Cybex 3.5M share secondary priced at $5.50.
<br />
(CYTC) Cytec noted positively in Barron’s online.
<br />
(DCEL) Dobson Communication largest holder entered into a variable share prepaid contract covering 7.2+M shares; started as Buy at Merrill Lynch.
<br />
(DLIA) Delia’s registered 4.1M shares for selling holders.
<br />
(FAL) Falconbridge gets buyout offer from Xstrata for remaining 80% not owned.
<br />
(GOL) Gol Linhas filed to sell preferred stock and convertible notes.
<br />
(HPQ) Hewlett Packard $0.54 EPS vs $0.49e; trading up$1.11 pre-market after beating earnings and raising guidance.
<br />
(LCRD) Lasercard $0.15 EPS vs $0.13e.
<br />
(MDT) Medtronic received FDA approval for Concerto and Virtuoso line of cardiac devices.
<br />
(NCBC) New Century Bancorp filed to sell 1M share of common stock.
<br />
(NCOG) NCO Group formed a special committee and retained advisors for the CEO’s $27.50 per share going private offer.
<br />
(NTES) Netease.com $0.26 EPS vs $0.23e; stock up 3% pre-market.
<br />
(NVL) Novelis $0.14 EPS vs $0.16e.
<br />
(NXTM) NxStage Medical filed to sell 6M shares of common stock.
<br />
(PFG) Principal Financial approved up to $500M in share buybacks.
<br />
(PLAB) Photronics $0.30 EPS vs $0.21e; R$119.5M vs $115.7M(e).
<br />
(PNSN) Penson 7.7+M share IPO priced at $17.00.
<br />
(REDE) Red Envelope hired WRHambrecht as financial advisor after posting wider than expected losses.
<br />
(REST) Restore Medical 4M share IPO priced at $8.00.
<br />
(RICK) Rick’s Cabaret raised net income guidance.
<br />
(RIGL) Rigel’s R343 compound selected by Pfizer; will get $5M milestone payment.
<br />
(RLH) Red Lion Hotels 5.6M share secondary priced at $11.00.
<br />
(RTLX) Retailix $0.18/R$50.7M vs $0.20/$48.35M(e).
<br />
(SPWR) SunPower filed to sell 7M shares of common stock.
<br />
(SVC) Stewart & Stevenson received contract modifications w/ $625M total value.
<br />
(THC) Tenet Healthcare announced $21M civil settlement in San Diego hospital case.
<br />
(TNM) Thomas Nelson $0.42 EPS vs $0.48e.
<br />
(TOO) Too Inc. $0.35 EPS vs $0.30e.
<br />
(TRB) Tribune revenues in April fell another 3%.
<br />
(UAG) United Auto Group filed to sell $375M in debt.
<br />
(VSAT) Viasat $0.28 EPS as expected.
<br />
(XMSR) XM sued by recording industry over handheld devices.
<br />
(YHOO) Yahoo is seeking to narrow the gap in its search and Google’s according to Financial Times.
<br />
(ZLC) Zale’s $0.24 EPS vs $0.21e.
<br />
(ZMH) Zimmer noted positively in Barron’s online.
<br />
(ZUMZ) Zumiez announced it will acquire action sport retailer Fast Forward.
</p>]]>
      </content>
      <pubDate>Wed, 17 May 2006 09:00:04 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong>
</p>
<p>S&P Fair Value +$1.03.
</p>
<p>(AMAT) Applied Materials $0.29 EPS vs $0.23e; R$2.25B vs $2.15B(e);new orders $2.49B; stock trading down 1.8% pre-market.
<br />
(ANF) Abercrombie & Fitch $0.62 EPS vs $0.54e.
<br />
(AZN) AstraZeneca NXY-059 is safe in stroke studies and will seek FDA approval in 2007.
<br />
(BIDU) Baidu.com up 1% on hard disk search pact with IBM.
<br />
(CD) Cendant’s travel business are reportedly being looked at by private equity firms.
<br />
(CHRS) Charming Shoppes $0.24 EPS vs $0.24e.
<br />
(CPWR) Compuware $0.15 EPS vs $0.13e; R$309.48M vs $309.9M(e).
<br />
(CYB) Cybex 3.5M share secondary priced at $5.50.
<br />
(CYTC) Cytec noted positively in Barron’s online.
<br />
(DCEL) Dobson Communication largest holder entered into a variable share prepaid contract covering 7.2+M shares; started as Buy at Merrill Lynch.
<br />
(DLIA) Delia’s registered 4.1M shares for selling holders.
<br />
(FAL) Falconbridge gets buyout offer from Xstrata for remaining 80% not owned.
<br />
(GOL) Gol Linhas filed to sell preferred stock and convertible notes.
<br />
(HPQ) Hewlett Packard $0.54 EPS vs $0.49e; trading up$1.11 pre-market after beating earnings and raising guidance.
<br />
(LCRD) Lasercard $0.15 EPS vs $0.13e.
<br />
(MDT) Medtronic received FDA approval for Concerto and Virtuoso line of cardiac devices.
<br />
(NCBC) New Century Bancorp filed to sell 1M share of common stock.
<br />
(NCOG) NCO Group formed a special committee and retained advisors for the CEO’s $27.50 per share going private offer.
<br />
(NTES) Netease.com $0.26 EPS vs $0.23e; stock up 3% pre-market.
<br />
(NVL) Novelis $0.14 EPS vs $0.16e.
<br />
(NXTM) NxStage Medical filed to sell 6M shares of common stock.
<br />
(PFG) Principal Financial approved up to $500M in share buybacks.
<br />
(PLAB) Photronics $0.30 EPS vs $0.21e; R$119.5M vs $115.7M(e).
<br />
(PNSN) Penson 7.7+M share IPO priced at $17.00.
<br />
(REDE) Red Envelope hired WRHambrecht as financial advisor after posting wider than expected losses.
<br />
(REST) Restore Medical 4M share IPO priced at $8.00.
<br />
(RICK) Rick’s Cabaret raised net income guidance.
<br />
(RIGL) Rigel’s R343 compound selected by Pfizer; will get $5M milestone payment.
<br />
(RLH) Red Lion Hotels 5.6M share secondary priced at $11.00.
<br />
(RTLX) Retailix $0.18/R$50.7M vs $0.20/$48.35M(e).
<br />
(SPWR) SunPower filed to sell 7M shares of common stock.
<br />
(SVC) Stewart & Stevenson received contract modifications w/ $625M total value.
<br />
(THC) Tenet Healthcare announced $21M civil settlement in San Diego hospital case.
<br />
(TNM) Thomas Nelson $0.42 EPS vs $0.48e.
<br />
(TOO) Too Inc. $0.35 EPS vs $0.30e.
<br />
(TRB) Tribune revenues in April fell another 3%.
<br />
(UAG) United Auto Group filed to sell $375M in debt.
<br />
(VSAT) Viasat $0.28 EPS as expected.
<br />
(XMSR) XM sued by recording industry over handheld devices.
<br />
(YHOO) Yahoo is seeking to narrow the gap in its search and Google’s according to Financial Times.
<br />
(ZLC) Zale’s $0.24 EPS vs $0.21e.
<br />
(ZMH) Zimmer noted positively in Barron’s online.
<br />
(ZUMZ) Zumiez announced it will acquire action sport retailer Fast Forward.
</p><br/><a href='http://seekingalpha.com/article/10790-wednesday-pre-market-notes-by-stock-ticker?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Evaluating the Implosion in Neurocrine Biosciences (NBIX, DOVP, SEPR, KG)</title>
      <link>http://seekingalpha.com/article/10733-evaluating-the-implosion-in-neurocrine-biosciences-nbix-dovp-sepr-kg?source=feed</link>
      <guid isPermaLink="false">10733</guid>
      <content>
        <![CDATA[This situation on Neurocrine Biosciences (NBIX) is quite puzzling, and perhaps outright troubling.  The FDA earlier gave only a partial "Approvable" nod to its investigational drug Indiplon for insomnia, a very common sleep disorder.  Neurocrine shares are down a massive 59.4% to $22.14 this morning, a level which puts the company at 5-year lows.<!--more-->  

<p>Some of this may not even be the company's fault depending on how you read into it, and when you see blow-ups like this it leaves little doubt as to why so many investors avoid development-stage biotech companies.
</p>
<p>Here are the guts of the press release:
</p>]]>
      </content>
      <pubDate>Tue, 16 May 2006 13:34:52 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[This situation on Neurocrine Biosciences (NBIX) is quite puzzling, and perhaps outright troubling.  The FDA earlier gave only a partial "Approvable" nod to its investigational drug Indiplon for insomnia, a very common sleep disorder.  Neurocrine shares are down a massive 59.4% to $22.14 this morning, a level which puts the company at 5-year lows.<!--more-->  

<p>Some of this may not even be the company's fault depending on how you read into it, and when you see blow-ups like this it leaves little doubt as to why so many investors avoid development-stage biotech companies.
</p>
<p>Here are the guts of the press release:
</p><br/><a href='http://seekingalpha.com/article/10733-evaluating-the-implosion-in-neurocrine-biosciences-nbix-dovp-sepr-kg?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/dovp">DOVP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/kg">KG</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nbix">NBIX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/sepr">SEPR</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>This Week's IPOs: Burger King, Darwin Professional Underwriters, Penson Worldwide (BKC, DR, PNSN)</title>
      <link>http://seekingalpha.com/article/10651-this-week-s-ipos-burger-king-darwin-professional-underwriters-penson-worldwide-bkc-dr-pnsn?source=feed</link>
      <guid isPermaLink="false">10651</guid>
      <content>
        <![CDATA[This is not an extremely busy week in IPO-land, but we have a key IPO and there is of course always plenty of news and many developments worth looking at.
</p>
<p>The largest IPO and the one the street has its eye on is of course Burger King Holdings that will trade under the ticker BKC.  It is presumable that if you haven't been locked up for thirty years and that if you are reading this that you already know they are one of the top fast food and burger interests in the US and abroad.  The underwriting group is lead by J.P.Morgan and the co-manager group is quite large: Citigroup, Goldman Sachs, Morgan Stanley, Wachovia, Bear Stearns, CSFB, Lehman, and Loop Capital Markets.  
</p>]]>
      </content>
      <pubDate>Mon, 15 May 2006 16:16:49 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[This is not an extremely busy week in IPO-land, but we have a key IPO and there is of course always plenty of news and many developments worth looking at.
</p>
<p>The largest IPO and the one the street has its eye on is of course Burger King Holdings that will trade under the ticker BKC.  It is presumable that if you haven't been locked up for thirty years and that if you are reading this that you already know they are one of the top fast food and burger interests in the US and abroad.  The underwriting group is lead by J.P.Morgan and the co-manager group is quite large: Citigroup, Goldman Sachs, Morgan Stanley, Wachovia, Bear Stearns, CSFB, Lehman, and Loop Capital Markets.  
</p><br/><a href='http://seekingalpha.com/article/10651-this-week-s-ipos-burger-king-darwin-professional-underwriters-penson-worldwide-bkc-dr-pnsn?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/bkc">BKC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ctcm">CTCM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/dr">DR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/maq">MAQ</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pnsn">PNSN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/qtrx">QTRX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/rest">REST</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Monday Pre-Market Notes By Stock Ticker</title>
      <link>http://seekingalpha.com/article/10634-monday-pre-market-notes-by-stock-ticker?source=feed</link>
      <guid isPermaLink="false">10634</guid>
      <content>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong> 
</p>
<p>S&P FAIR VALUE +$1.04.
</p>
<p>(ACR) American Retirement Corp gets $33 buyout from BKD-Brookdale.
<br />
(ALXN) Alexion said its antibody was effective in blocking inflammation in the lungs.
<br />
(ANDE) Anderson’s announced a 2 for 1 stock split.
<br />
(AVGN) Avigen sold 3.9M shares in private placement at $5.37.
<br />
(BA) Boeing is paying the DOJ $615M to avoid criminal charges in contract scandal settlement.
<br />
(BEE) Strategic Hotels & Resorts will sell 14M shares.
<br />
(BIVN) Bioenvision -$0.15 EPS vs -$0.15e.
<br />
(CA) Computer Associates CFO Bob Davis is leaving the company under a mutual agreement; its Controller Robert Cirabisi will assume the role during an external search.
<br />
(CAI) CACI Int’l noted as potential takeover candidate of BAE Systems in UK.
<br />
(BRKS) Brooks Automation gets informal inquiry from the SEC over option grants.
<br />
(CATG) Cambridge Antibody noted as potential takeover candidate of AstraZeneca according to the Observer in the UK.
<br />
(CRI) Carter’s announced a 2 for 1 stock split.
<br />
(DCI)Donaldson gets supply pact from DaimlerChrysler.
<br />
(EXTR) Extreme Networks CEO will retire this year.
<br />
(GBX) Greenbriar will pay $2.9M and take a charge over an IRS tax settlement.
<br />
(HLSH) Healthsouth will pay $25M to settle shareholder suit.
<br />
(HYGS) Hydrogenics announced 5-year supply pact with Linde AG’g gas division.
<br />
(INO) Inovio Biomed filed for $74M mixed securities shelf offering.
<br />
(IOMG) I/O Magic gets $2.38M from Office Max in litigation settlement.
<br />
(JOYG) Joy Global CFO is retiring.
<br />
(KNTA) Kintera -$0.26 EPS vs -$0.26e.
<br />
(LEAP) Leap Wireless will sell 5.6M shares.
<br />
(MODT) Modtech -$0.23 EPS vs $0.03e (-$0.01 est elsewhere) after option charges; guides R$ in 2006 at $230M to $250M..
<br />
(MSFT) Microsoft is looking for “the next big thing” according to Financial Times.
<br />
(NVAX) Novavax -$0.11 EPS vs -$0.14e; non-revenue stage.
<br />
(NWS) News Corp’s Myspace.com is becoming a new portal with downloads and ads according to WSJ.
<br />
(ODP) Office Depot announced new 4500M share buyback plan.
<br />
(OTEX) Open Text announced a 2.4M share buyback plan.
<br />
(PETS) Petmed Express $0.13 EPS vs $0.13e.
<br />
(Q) Qwest is paying $107M to acquire OnFiber Communications.
<br />
(RADA) Radica Games -$0.05 EPS vs $0.00e, but R$18.5M vs $14.9M(e).
<br />
(RMX) Ready-Mix $0.19 EPS vs $0.12e.
<br />
(RNAI) Sirna Therapeutics filed to sell 10M shares, 8M of which are from the company.
<br />
(RVSN) Radvision gets supply pact from Atmel.
<br />
(SCSS) Select Comfort announced 3 for 2 stock split and 4150M share buyback plan.
<br />
(SVC) Stewart & Stevenson gets higher 436.50 revised offer from AH-Armor Holdings.
<br />
(VOD) Vodafone may be interested in selling its Verizon Wireless stake according to the Observer in the UK.
</p>]]>
      </content>
      <pubDate>Mon, 15 May 2006 09:06:51 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong> 
</p>
<p>S&P FAIR VALUE +$1.04.
</p>
<p>(ACR) American Retirement Corp gets $33 buyout from BKD-Brookdale.
<br />
(ALXN) Alexion said its antibody was effective in blocking inflammation in the lungs.
<br />
(ANDE) Anderson’s announced a 2 for 1 stock split.
<br />
(AVGN) Avigen sold 3.9M shares in private placement at $5.37.
<br />
(BA) Boeing is paying the DOJ $615M to avoid criminal charges in contract scandal settlement.
<br />
(BEE) Strategic Hotels & Resorts will sell 14M shares.
<br />
(BIVN) Bioenvision -$0.15 EPS vs -$0.15e.
<br />
(CA) Computer Associates CFO Bob Davis is leaving the company under a mutual agreement; its Controller Robert Cirabisi will assume the role during an external search.
<br />
(CAI) CACI Int’l noted as potential takeover candidate of BAE Systems in UK.
<br />
(BRKS) Brooks Automation gets informal inquiry from the SEC over option grants.
<br />
(CATG) Cambridge Antibody noted as potential takeover candidate of AstraZeneca according to the Observer in the UK.
<br />
(CRI) Carter’s announced a 2 for 1 stock split.
<br />
(DCI)Donaldson gets supply pact from DaimlerChrysler.
<br />
(EXTR) Extreme Networks CEO will retire this year.
<br />
(GBX) Greenbriar will pay $2.9M and take a charge over an IRS tax settlement.
<br />
(HLSH) Healthsouth will pay $25M to settle shareholder suit.
<br />
(HYGS) Hydrogenics announced 5-year supply pact with Linde AG’g gas division.
<br />
(INO) Inovio Biomed filed for $74M mixed securities shelf offering.
<br />
(IOMG) I/O Magic gets $2.38M from Office Max in litigation settlement.
<br />
(JOYG) Joy Global CFO is retiring.
<br />
(KNTA) Kintera -$0.26 EPS vs -$0.26e.
<br />
(LEAP) Leap Wireless will sell 5.6M shares.
<br />
(MODT) Modtech -$0.23 EPS vs $0.03e (-$0.01 est elsewhere) after option charges; guides R$ in 2006 at $230M to $250M..
<br />
(MSFT) Microsoft is looking for “the next big thing” according to Financial Times.
<br />
(NVAX) Novavax -$0.11 EPS vs -$0.14e; non-revenue stage.
<br />
(NWS) News Corp’s Myspace.com is becoming a new portal with downloads and ads according to WSJ.
<br />
(ODP) Office Depot announced new 4500M share buyback plan.
<br />
(OTEX) Open Text announced a 2.4M share buyback plan.
<br />
(PETS) Petmed Express $0.13 EPS vs $0.13e.
<br />
(Q) Qwest is paying $107M to acquire OnFiber Communications.
<br />
(RADA) Radica Games -$0.05 EPS vs $0.00e, but R$18.5M vs $14.9M(e).
<br />
(RMX) Ready-Mix $0.19 EPS vs $0.12e.
<br />
(RNAI) Sirna Therapeutics filed to sell 10M shares, 8M of which are from the company.
<br />
(RVSN) Radvision gets supply pact from Atmel.
<br />
(SCSS) Select Comfort announced 3 for 2 stock split and 4150M share buyback plan.
<br />
(SVC) Stewart & Stevenson gets higher 436.50 revised offer from AH-Armor Holdings.
<br />
(VOD) Vodafone may be interested in selling its Verizon Wireless stake according to the Observer in the UK.
</p><br/><a href='http://seekingalpha.com/article/10634-monday-pre-market-notes-by-stock-ticker?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Wi-Max Pioneer Clearwire Files For an IPO (CLWR)</title>
      <link>http://seekingalpha.com/article/10516-wi-max-pioneer-clearwire-files-for-an-ipo-clwr?source=feed</link>
      <guid isPermaLink="false">10516</guid>
      <content>
        <![CDATA[<p><img src="http://static.seekingalpha.com/wp-content/seekingalpha/images/clearwirelogo.gif" border="0" height="85" align="right" width="230" /> <strong> <a href="http://blog.newscontrast.com/">Jon Ogg submits: </a></strong> One of the first pure-play Wi-Max companies with an existing coverage footprint in the US may soon be public.  Craig McCaw's wireless broadband provider Clearwire has filed to debut in an IPO with a stock sale of $400M.  
<br />
<!--more-->
<br />
We haven't seen an indication on the number of shares but the underwriting group is fairly large.  Merrill Lynch & Co., Morgan Stanley and JPMorgan would be the lead underwriters, with Bear Stearns and Wachovia also in the underwriting.   
</p>
<p>McCaw, who is chairman and co-chief executive, founded Clearwire in October 2003, and the company entered its first market in August 2004. As of March 31, Clearwire offered services in 27 markets in the US, as well as Brussels and Dublin in the EU.  The company reported a 2005 net loss of $139.95 million on $33.45 million in Revenues.  
</p>]]>
      </content>
      <pubDate>Fri, 12 May 2006 02:55:06 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[<p><img src="http://static.seekingalpha.com/wp-content/seekingalpha/images/clearwirelogo.gif" border="0" height="85" align="right" width="230" /> <strong> <a href="http://blog.newscontrast.com/">Jon Ogg submits: </a></strong> One of the first pure-play Wi-Max companies with an existing coverage footprint in the US may soon be public.  Craig McCaw's wireless broadband provider Clearwire has filed to debut in an IPO with a stock sale of $400M.  
<br />
<!--more-->
<br />
We haven't seen an indication on the number of shares but the underwriting group is fairly large.  Merrill Lynch & Co., Morgan Stanley and JPMorgan would be the lead underwriters, with Bear Stearns and Wachovia also in the underwriting.   
</p>
<p>McCaw, who is chairman and co-chief executive, founded Clearwire in October 2003, and the company entered its first market in August 2004. As of March 31, Clearwire offered services in 27 markets in the US, as well as Brussels and Dublin in the EU.  The company reported a 2005 net loss of $139.95 million on $33.45 million in Revenues.  
</p><br/><a href='http://seekingalpha.com/article/10516-wi-max-pioneer-clearwire-files-for-an-ipo-clwr?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/clwr">CLWR</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>News Corp's Earnings: The Impact Of MySpace (NWS)</title>
      <link>http://seekingalpha.com/article/10441-news-corp-s-earnings-the-impact-of-myspace-nws?source=feed</link>
      <guid isPermaLink="false">10441</guid>
      <content>
        <![CDATA[After reporting strong earnings, News Corp (NWS) traded up 2.51% after hours to $19.60 (versus a $19.12 close).  Going into earnings today, options traders looked like they had factored in a move of up to $0.60 in either direction, which was about 3% at current levels.  Analysts were still mixed, but the current trend and feel was more positive after it was all said and done.  
<br />
<!--more-->
<br />
Keep in mind that NWS has only officially been labeled a US-based company for a fairly small time compared to most S&P 500 Index components, so it is not officially as widely followed as some other big media companies.  Please look at the chart following this article to see the importance of the after-hours activity in the stock.

<p>News Corp reported earnings of $820M, operating income of $1.0 Billion, net revenues of $6.19+ Billion, and it applied an EPS number of $0.26 on a diluted combined basis.  The company also hiked its current share buyback plan from $3 Billion to $6 Billion to be completed in the coming 2-years "as the market undervalues the company" according to Murdoch on the conference call (see <a href="http://mediastockblog.com/article/10438">full transcript</a>).  It had already made $2.5 Billion in share buybacks of the current $3 Billion buyback plan.  The company also said it was comfortable with its guidance for the year that was offered in February.
</p>
<p>It is probably not surprising that print operating income fell 9%, but we finally got to interpolate some company-released figures on Myspace.com.  The company said it has <strong>over 70 Million registered users</strong>, and in the conference call said it was nearing<strong> 80 Million users.</strong>  Of the $6.19+ Billion in revenues for the quarter, it said <strong>"other" operations (which would include New Media Initiatives) were $359M in revenues and a loss in "other" operations of $49M.</strong>
</p>]]>
      </content>
      <pubDate>Thu, 11 May 2006 02:38:57 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[After reporting strong earnings, News Corp (NWS) traded up 2.51% after hours to $19.60 (versus a $19.12 close).  Going into earnings today, options traders looked like they had factored in a move of up to $0.60 in either direction, which was about 3% at current levels.  Analysts were still mixed, but the current trend and feel was more positive after it was all said and done.  
<br />
<!--more-->
<br />
Keep in mind that NWS has only officially been labeled a US-based company for a fairly small time compared to most S&P 500 Index components, so it is not officially as widely followed as some other big media companies.  Please look at the chart following this article to see the importance of the after-hours activity in the stock.

<p>News Corp reported earnings of $820M, operating income of $1.0 Billion, net revenues of $6.19+ Billion, and it applied an EPS number of $0.26 on a diluted combined basis.  The company also hiked its current share buyback plan from $3 Billion to $6 Billion to be completed in the coming 2-years "as the market undervalues the company" according to Murdoch on the conference call (see <a href="http://mediastockblog.com/article/10438">full transcript</a>).  It had already made $2.5 Billion in share buybacks of the current $3 Billion buyback plan.  The company also said it was comfortable with its guidance for the year that was offered in February.
</p>
<p>It is probably not surprising that print operating income fell 9%, but we finally got to interpolate some company-released figures on Myspace.com.  The company said it has <strong>over 70 Million registered users</strong>, and in the conference call said it was nearing<strong> 80 Million users.</strong>  Of the $6.19+ Billion in revenues for the quarter, it said <strong>"other" operations (which would include New Media Initiatives) were $359M in revenues and a loss in "other" operations of $49M.</strong>
</p><br/><a href='http://seekingalpha.com/article/10441-news-corp-s-earnings-the-impact-of-myspace-nws?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/nws">NWS</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Wednesday Pre-Market Notes by Stock Ticker</title>
      <link>http://seekingalpha.com/article/10388-wednesday-pre-market-notes-by-stock-ticker?source=feed</link>
      <guid isPermaLink="false">10388</guid>
      <content>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong> 
</p>
<p>S&P FAIR VALUE +$0.14.
</p>
<p>(ADL) AMDL registered to sell 10.5M shares for selling holders.
<br />
(AHGP) Alliance Holdings IPO priced 12.5M shares at $25.00, at the high-end of the range.
<br />
(ATAR) Atari raised $13M by selling non-core gaming names.
<br />
(AWR) American States Water $0.35 EPS vs $0.25e; unsure if comparable.
<br />
(BECN) Beacon Roofing $0.16 EPS vs $0..10e.
<br />
(BIDU) Baidu.com shares up almost 30% pre-market on blow-out quarter and guidance.
<br />
(BOFL) Bancshares of Florida 2.5M share secondary priced at $21.50.
<br />
(BOOM) Dynamic Materials priced its 5.15M share secondary at $35.00; versus $35.77 close.
<br />
(CEGE) Cell Genesys gets FDA Fast Track status for GVAX Immunotherapy.
<br />
(CRL) Charles River Labs $0.50 EPS vs $0.56e.
<br />
(CRYP) Cryptologic gets 3-year gaming site feature pact with Playboy.
<br />
(CSCO) Cisco Systems $0.29 EPS vs $0.26e; R$7.3B vs $7.16B(e); general guidance deemed tepid by many as revenues were not raised above guidance; stock down almost 1% pre-market.
<br />
(CTEC) Cholestec $0.14 EPS vs $0.11e.
<br />
(DIS) Disney $0.37 EPS vs $0.31e; R$8.0269B vs $8.18B(e).
<br />
(FWLT) Foster Wheeler $0.23/R$645.8M vs $0.38/$680M(e); stock Down 4% pre-market.
<br />
(HAWK) Petrohawk Energy $0.39 EPS vs $0.21e.
<br />
(HGSI) Human Genome Science -$0.47 EPS vs -$0.49e.
<br />
(HW) HW announced a hydrogen peroxide acquisition to expand capacity.
<br />
(IFX) Infineon’s board has approved an IPO of its memory unit as expected.
<br />
(IMAX) Imax signed a theatre agreement in Louisiana.
<br />
(LEAP) Leap Wireless $0.29 vs $0.06 (unsure if gains) and R$266.7M vs $246M(e); will raise $250M to bid on wireless licenses; share rose 4% after-hours.
<br />
(MIR) Mirant $0.46 EPS vs $0.23e; stock up almost 5%.
<br />
(MFLX) Multi-Fineline $0.49 EPS vs $0.51e; guidance soft.
<br />
(MSFT) Microsoft unveils its “Office of the Future” in Washington today.
<br />
(NICE) Nice Systems $0.42 EPS vs $0.40e.
<br />
(NOVC) Novacea IPO priced 6.25M shares at $6.50, under the original $7.00 to $8.00 range.
<br />
(NWS) News Corp reportedly in talks to acquire a Turkish media company “TGRT.”
<br />
(OSTK) Overstock.com down 12% on an SEC subpoena.
<br />
(PVH) Phillips Van-Heusen 10.1M share secondary priced at $38.00.
<br />
(PXG) Phoenix Footwear CEO is leaving for entrepreneurial interests.
<br />
(RMIX) US Concrete -$0.08 EPS vs -$0.06e; sees next Q $0.18-0.23 vs $0.24e.
<br />
(RMK) ARAMARK $0.32 EPS vs $0.29e.
<br />
(RRI) Reliant -$0.46 EPS vs -$0.34e, but R$2.45B vs $2.2B(e).
<br />
(SFCC) SFBC stock down 24% pre-market on weaker than expected results.
<br />
(SNDK) SanDisk noted as alternative MP3 player product for those that don’t want an Apple iPod in Business Week online.
<br />
(SYMC) Symantec $0.26/R$1.3B vs $0.25/$1.27B(e); guides Q1 0.20-0.21/R$1.2-1.25B vs $0.24/$1.25B(e); sees FY EPS $1.05-1.15 vs 1.11-1.12e and R$5.3-5.5B vs $5.35B(e).
<br />
(TASR) Taser announced another lawsuit against the company was dismissed;
<br />
(TEVA) Teva $0.37/R$1.67B vs $0.41/$1.88B(e).
<br />
(TM’) Toyota stock up 5% after earnings.
<br />
(TWX) Time Warner featuring an investor day conference.
<br />
(TXN) Texas Instruments has an analyst day today.
<br />
(TZOO) Travelzoo up 4% after showing over 100 advertisers.
<br />
(UARM) Under Armor registers 6.815M Shares for selling holders.
<br />
(UNH) United Healthcare up 0.6% pre-market as Citigroup said the stock could double over the next couple of years.
<br />
(VZ) Verizon considering selling some of its landline business according to WSJ.
<br />
(WEDC) White Electronic Design $0.07 EPS vs $0.06e.
<br />
(WFMI) Whole Foods supposedly running “values and deals” ads over next 10 days according to New York Times.
<br />
(WSSI) Webside Story $0.12 EPS vs $0.11e.
</p>]]>
      </content>
      <pubDate>Wed, 10 May 2006 09:15:44 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong> 
</p>
<p>S&P FAIR VALUE +$0.14.
</p>
<p>(ADL) AMDL registered to sell 10.5M shares for selling holders.
<br />
(AHGP) Alliance Holdings IPO priced 12.5M shares at $25.00, at the high-end of the range.
<br />
(ATAR) Atari raised $13M by selling non-core gaming names.
<br />
(AWR) American States Water $0.35 EPS vs $0.25e; unsure if comparable.
<br />
(BECN) Beacon Roofing $0.16 EPS vs $0..10e.
<br />
(BIDU) Baidu.com shares up almost 30% pre-market on blow-out quarter and guidance.
<br />
(BOFL) Bancshares of Florida 2.5M share secondary priced at $21.50.
<br />
(BOOM) Dynamic Materials priced its 5.15M share secondary at $35.00; versus $35.77 close.
<br />
(CEGE) Cell Genesys gets FDA Fast Track status for GVAX Immunotherapy.
<br />
(CRL) Charles River Labs $0.50 EPS vs $0.56e.
<br />
(CRYP) Cryptologic gets 3-year gaming site feature pact with Playboy.
<br />
(CSCO) Cisco Systems $0.29 EPS vs $0.26e; R$7.3B vs $7.16B(e); general guidance deemed tepid by many as revenues were not raised above guidance; stock down almost 1% pre-market.
<br />
(CTEC) Cholestec $0.14 EPS vs $0.11e.
<br />
(DIS) Disney $0.37 EPS vs $0.31e; R$8.0269B vs $8.18B(e).
<br />
(FWLT) Foster Wheeler $0.23/R$645.8M vs $0.38/$680M(e); stock Down 4% pre-market.
<br />
(HAWK) Petrohawk Energy $0.39 EPS vs $0.21e.
<br />
(HGSI) Human Genome Science -$0.47 EPS vs -$0.49e.
<br />
(HW) HW announced a hydrogen peroxide acquisition to expand capacity.
<br />
(IFX) Infineon’s board has approved an IPO of its memory unit as expected.
<br />
(IMAX) Imax signed a theatre agreement in Louisiana.
<br />
(LEAP) Leap Wireless $0.29 vs $0.06 (unsure if gains) and R$266.7M vs $246M(e); will raise $250M to bid on wireless licenses; share rose 4% after-hours.
<br />
(MIR) Mirant $0.46 EPS vs $0.23e; stock up almost 5%.
<br />
(MFLX) Multi-Fineline $0.49 EPS vs $0.51e; guidance soft.
<br />
(MSFT) Microsoft unveils its “Office of the Future” in Washington today.
<br />
(NICE) Nice Systems $0.42 EPS vs $0.40e.
<br />
(NOVC) Novacea IPO priced 6.25M shares at $6.50, under the original $7.00 to $8.00 range.
<br />
(NWS) News Corp reportedly in talks to acquire a Turkish media company “TGRT.”
<br />
(OSTK) Overstock.com down 12% on an SEC subpoena.
<br />
(PVH) Phillips Van-Heusen 10.1M share secondary priced at $38.00.
<br />
(PXG) Phoenix Footwear CEO is leaving for entrepreneurial interests.
<br />
(RMIX) US Concrete -$0.08 EPS vs -$0.06e; sees next Q $0.18-0.23 vs $0.24e.
<br />
(RMK) ARAMARK $0.32 EPS vs $0.29e.
<br />
(RRI) Reliant -$0.46 EPS vs -$0.34e, but R$2.45B vs $2.2B(e).
<br />
(SFCC) SFBC stock down 24% pre-market on weaker than expected results.
<br />
(SNDK) SanDisk noted as alternative MP3 player product for those that don’t want an Apple iPod in Business Week online.
<br />
(SYMC) Symantec $0.26/R$1.3B vs $0.25/$1.27B(e); guides Q1 0.20-0.21/R$1.2-1.25B vs $0.24/$1.25B(e); sees FY EPS $1.05-1.15 vs 1.11-1.12e and R$5.3-5.5B vs $5.35B(e).
<br />
(TASR) Taser announced another lawsuit against the company was dismissed;
<br />
(TEVA) Teva $0.37/R$1.67B vs $0.41/$1.88B(e).
<br />
(TM’) Toyota stock up 5% after earnings.
<br />
(TWX) Time Warner featuring an investor day conference.
<br />
(TXN) Texas Instruments has an analyst day today.
<br />
(TZOO) Travelzoo up 4% after showing over 100 advertisers.
<br />
(UARM) Under Armor registers 6.815M Shares for selling holders.
<br />
(UNH) United Healthcare up 0.6% pre-market as Citigroup said the stock could double over the next couple of years.
<br />
(VZ) Verizon considering selling some of its landline business according to WSJ.
<br />
(WEDC) White Electronic Design $0.07 EPS vs $0.06e.
<br />
(WFMI) Whole Foods supposedly running “values and deals” ads over next 10 days according to New York Times.
<br />
(WSSI) Webside Story $0.12 EPS vs $0.11e.
</p><br/><a href='http://seekingalpha.com/article/10388-wednesday-pre-market-notes-by-stock-ticker?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Earnings Preview: Cisco (CSCO)</title>
      <link>http://seekingalpha.com/article/10270-earnings-preview-cisco-csco?source=feed</link>
      <guid isPermaLink="false">10270</guid>
      <content>
        <![CDATA[Today is Cisco Systems' (CSCO) earnings report after the close.  Before going into all of the different metrics normally covered, please keep in mind that this quarter in particular will almost certainly look substantially different on a year-over-year and on a quarterly basis than in other quarters and it is going to potentially alter the way some analyst research reports look Wednesday and beyond.  
<br />
<!--more-->
<br />
In February, Cisco closed the Scientific-Atlanta acquisition (its largest acquisition in years) and during the quarter it acquired a 9.7% stake of Shanda Interactive (SNDA) based in Shanghai.  Dell's (DELL) lowered-guidance just after the close Monday may throw a wrench in the machine on these numbers and calculations in this and other major tech stocks, but Intel (INTC) is only down $0.11 and Microsoft (MSFT) is only down $0.04 in after-hours trading.

<p>Analysts expect earnings per share and revenues as follows:  <strong>EPS $0.26 & R$7.21B</strong>
</p>
<p>Earlier in the quarter the company forecast a multi-year revenue growth target of 10% to 15%; we now we should get to see just how all of the integrations in data transfer, hardware, Wi-Max, and security are all going to add to the top and bottom line.
</p>]]>
      </content>
      <pubDate>Tue, 09 May 2006 13:24:53 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[Today is Cisco Systems' (CSCO) earnings report after the close.  Before going into all of the different metrics normally covered, please keep in mind that this quarter in particular will almost certainly look substantially different on a year-over-year and on a quarterly basis than in other quarters and it is going to potentially alter the way some analyst research reports look Wednesday and beyond.  
<br />
<!--more-->
<br />
In February, Cisco closed the Scientific-Atlanta acquisition (its largest acquisition in years) and during the quarter it acquired a 9.7% stake of Shanda Interactive (SNDA) based in Shanghai.  Dell's (DELL) lowered-guidance just after the close Monday may throw a wrench in the machine on these numbers and calculations in this and other major tech stocks, but Intel (INTC) is only down $0.11 and Microsoft (MSFT) is only down $0.04 in after-hours trading.

<p>Analysts expect earnings per share and revenues as follows:  <strong>EPS $0.26 & R$7.21B</strong>
</p>
<p>Earlier in the quarter the company forecast a multi-year revenue growth target of 10% to 15%; we now we should get to see just how all of the integrations in data transfer, hardware, Wi-Max, and security are all going to add to the top and bottom line.
</p><br/><a href='http://seekingalpha.com/article/10270-earnings-preview-cisco-csco?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/csco">CSCO</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Tuesday Pre-Market Notes By Stock Ticker</title>
      <link>http://seekingalpha.com/article/10291-tuesday-pre-market-notes-by-stock-ticker?source=feed</link>
      <guid isPermaLink="false">10291</guid>
      <content>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong> 
</p>
<p>S&P FAIR VALUE +$1.96.
</p>
<p>(AAPL) Apple is reportedly selling Fox's TV shows on its iTunes site.
<br />
(ABMD) Abiocor -$0.14 EPS vs -$0.14e.
<br />
(ACL) Alcon company receives U.S. FDA approval for LADAR6000 excimer laser.
<br />
(AHC) Amerada Hess is selling 65 producing onshore wells in Gulf of Mexico coastal area.
<br />
(AIRM) Air Methods $0.21 EPS vs $0.17e.
<br />
(ANPI) Angiotech formed collaboration pact with Genzyme targeting tumors. Earnings were $0.19 EPS before items vs $0.16e; R$41.9M vs $49.65M(e).
<br />
(ANSW) Answers Corp -$0.10/R$1.15M vs -$0.14/$1.05M(e).
<br />
(AQNT) Aquantive $0.10/R$92.2M vs $0.06/$84.75M(e); guides higher; stock rose 7%.
<br />
(AT) Alltel has signed a 10-year roaming pact with Sprint-NexTel according to the WSJ.
<br />
(ATVI) Activision is acquiring game studio RedOctane.
<br />
(AUDC) Audiocodes $0.10 EPS vs $0.09e.
<br />
(AVNX) Avanex -$0.06/R$40.3M vs -$0.04/$39.9M(e).
<br />
(BID) Sotheby's -$0.07 EPS vs -$0.06e.
<br />
(CCRT) Compucredit $1.09 EPS vs $0.92e.
<br />
(CHD) Church & Dwight $0.60 EPS vs $0.53e.
<br />
(CMG) Chipotle $0.26 EPS vs $0.12e; unsure if comparable; filed to sell 4.19M shares of stock.
<br />
(COH) Coach announced $500M share buyback plan.
<br />
(CPE) Callon Petroleum $0.60 EPS vs $0.49e.
<br />
(CSV) Carriage Systems $0.13 EPS vs $0.13e.
<br />
(DELL) Dell fell 6% after-hours on guidance that was to the lower-end on revenues and under on EPS on price cuts; sees R$14.2 instead of $14.5B(e) and EPS $0.33 vs $0.38e.
<br />
(DIGE) Digene $0.13 EPS vs $0.11e.
<br />
(DTSI) DTS inc $0.38 EPS vs $0.32e.
<br />
(DYN) Dynegy -$0.01 EPS vs -$0.12e; but widened out loss projections for the year from prior range.
<br />
(EAGL) EGL $0.27 EPS vs $0.17e.
<br />
(ELOS) Syneron $0.37 EPS vs $0.42e.
<br />
(ENTG) Entegris $0.13 EPS vs $0.11e.
<br />
(FLR) Fluor $1.00 EPS vs $0.66e; R$3.6B vs $3.35B(e); raised 2006 EPS from $2.80-3.10 up to $2.90-3.20.
<br />
(FNM) Fannie Mae delayed quarterly filing.
<br />
(FTEK) Fuel Tech $0.06/R$17.1M vs $0.08/$14M(e); EPS had charge in number.
<br />
(FTI) FMC Tech $0.47 EPS vs $0.45e.
<br />
(GAP) Great Atlantic & Pacific Tea -$0.95 EPS after charges vs -$0.41e.
<br />
(GEMS) Glenayre -$0.10 EPS vs -$0.03e; notified by Sprint-NexTel that they are no longer being offered as voicemail service provider.
<br />
(GIII) G-III Aparrel filed to sell 4M shares of common stock.
<br />
(GKIS) Gold Kist -$0.32 EPS vs -$0.35e.
<br />
(GIVN) Given Imaging -$0.11/R$20.3M vs -$0.11/$20.2M(e).
<br />
(GNTA) Genta's NDA accepted by the FDA for Genasense plus chemotherapy in relapsed and refractory CLL.
<br />
(HANS) Hansen Natural up 18% pre-market after higher earnings.
<br />
(HB) Hillenbrand $0.89 EPS vs $0.84e.
<br />
(HELE) Helen of Troy $0.30 EPS & R$134.5M vs $0.16/$126.75M(e); EPS was $0.21 with items.
<br />
(HSP) Hospira $0.62 EPS vs $0.48e.
<br />
(IDTI) Integrated Device Tech $0.15/R$167.5M vs $0.15/$165.2M(e).
<br />
(IFO) Infosonics $0.22 EPS vs $0.09e; stock up 9%.
<br />
(IT) Gartner registered 9.5M shares for selling shareholder.
<br />
(KG) King Pharma $0.44 EPS vs $0.37e.
<br />
(KMGB) KMG Chemicals filed to sell 3M shares of common stock.
<br />
(KOSP) Kos Pharma -$0.06/R$170.8M vs $0.03/$173.7M(e); announced up to 7M share buyback plan.
<br />
(KND) Kindred Healthcare sees revenues $46M lower on Medicare or Medicaid reimbursements.
<br />
(L) Liberty Media $0.02/R$1.98B vs $0.02/$2.00B(e).
<br />
(LAZ) Lazard $0.51 EPS vs $0.47e.
<br />
(MCD) McDonalds reported 4.1% s-s-s growth in US for April; up 6.5% worldwide.
<br />
(MIDD) Middleby $0.97 EPS vs $0.90e.
<br />
(MIVA) Miva -$0.03 EPS vs -$0.09e; guidance looks light; unsure if comparable.
<br />
(MRK) Merck is acquiring private GlycoFi for $400M cash.
<br />
(MRX)  Medicis Pharma received FDA approval for its New Drug Application of SOLODYN for
<br />
acne therapy
<br />
(NYM) Nymagic $0.85 EPS vs $0.65e.
<br />
(OMG) OM Group $0.62 EPS vs $0.62e.
<br />
(OPMR) Optimal Robotics $0.27 EPS vs $0.25e.
<br />
(OSIP) OSI Pharma -$0.31/R$116.4M vs -$0.12/$122.3M(e).
<br />
(PKS) Six Flags -$0.94 EPS vs -$1.20e.
<br />
(QGEN) Qiagen $0.13 EPS vs $0.12e.
<br />
(RBAK) Redback Networks filed to sell 11.3M shares of common stock.
<br />
(RNT) Aaron rents filed to sell 4M shares of common stock.
<br />
(RSAS) RSA Security filed to sell 1.99M shares of common stock for holders.
<br />
(SBAC) SBA Communications -$0.11/R$68.8M vs -$0.12/$67.25M(e); guides revenues higher.
<br />
(SLE) Sara Lee sells its Courtald's business unit.
<br />
(SRVY) Greenfield Online $0.03 EPS vs $0.00e.
<br />
(SWSI) Superior Wells $0.33 EPS vs $0.24e.
<br />
(SYGR) Synagro registered to sell 17.1M shares of common stock, only 2M are for the company.
<br />
(SYKE) Sykes Enterprises $0.15/R$131.1M EPS vs $0.10e/$127.9M(e).
<br />
(TGEN) Targeted Genetics authorized a 1-10 reverse split.
<br />
(THC) Tenet Healthcare $0.03/R$2.41B vs -$0.02/R$2.46B(e).
<br />
(TOA) Technical Olympic $0.89 EPS vs $0.82e.
<br />
(TRAK) Dealer Track $0.18 EPS vs $0.15e.
<br />
(TRFC) Traffic.com -$0.49/R$10.8M vs -$0.54/$10.78M(e).
<br />
(TWPG) Thomas Weisel filed to sell 4.5M shares of stock.
<br />
(USIH) USI Holdings $0.30 EPS vs $0.32e.
<br />
(V&TWX) Vivendi is reportedly creating a big budget fantasy/action film with Time's Warner Brothers unit based upon Vivendi's Blizzard unit hit game "World of Warcraft."
<br />
(VAS) Viasys $0.23 EPS vs $0.22e.
<br />
(VCLK) Valueclick $0.09/R$117M vs $0.11/$112M(e)revenue guidance looks in-line but EPS looks light.
<br />
(VTIV) Ventiv $0.34 EPS vs $0.30e.
<br />
(WGII) Washington Group $0.62 EPS vs $0.51e.
<br />
(WR) Westar Energy $0.30 EPS vs $0.25e.
<br />
(WWCA) WCA Waste $0.04 EPS vs $0.04e.
<br />
(ZIPR) Zip Realty -$0.04/R$19.2M vs -$0.16/$17.25M(e); guidance looks light.
</p>]]>
      </content>
      <pubDate>Tue, 09 May 2006 08:40:55 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong> 
</p>
<p>S&P FAIR VALUE +$1.96.
</p>
<p>(AAPL) Apple is reportedly selling Fox's TV shows on its iTunes site.
<br />
(ABMD) Abiocor -$0.14 EPS vs -$0.14e.
<br />
(ACL) Alcon company receives U.S. FDA approval for LADAR6000 excimer laser.
<br />
(AHC) Amerada Hess is selling 65 producing onshore wells in Gulf of Mexico coastal area.
<br />
(AIRM) Air Methods $0.21 EPS vs $0.17e.
<br />
(ANPI) Angiotech formed collaboration pact with Genzyme targeting tumors. Earnings were $0.19 EPS before items vs $0.16e; R$41.9M vs $49.65M(e).
<br />
(ANSW) Answers Corp -$0.10/R$1.15M vs -$0.14/$1.05M(e).
<br />
(AQNT) Aquantive $0.10/R$92.2M vs $0.06/$84.75M(e); guides higher; stock rose 7%.
<br />
(AT) Alltel has signed a 10-year roaming pact with Sprint-NexTel according to the WSJ.
<br />
(ATVI) Activision is acquiring game studio RedOctane.
<br />
(AUDC) Audiocodes $0.10 EPS vs $0.09e.
<br />
(AVNX) Avanex -$0.06/R$40.3M vs -$0.04/$39.9M(e).
<br />
(BID) Sotheby's -$0.07 EPS vs -$0.06e.
<br />
(CCRT) Compucredit $1.09 EPS vs $0.92e.
<br />
(CHD) Church & Dwight $0.60 EPS vs $0.53e.
<br />
(CMG) Chipotle $0.26 EPS vs $0.12e; unsure if comparable; filed to sell 4.19M shares of stock.
<br />
(COH) Coach announced $500M share buyback plan.
<br />
(CPE) Callon Petroleum $0.60 EPS vs $0.49e.
<br />
(CSV) Carriage Systems $0.13 EPS vs $0.13e.
<br />
(DELL) Dell fell 6% after-hours on guidance that was to the lower-end on revenues and under on EPS on price cuts; sees R$14.2 instead of $14.5B(e) and EPS $0.33 vs $0.38e.
<br />
(DIGE) Digene $0.13 EPS vs $0.11e.
<br />
(DTSI) DTS inc $0.38 EPS vs $0.32e.
<br />
(DYN) Dynegy -$0.01 EPS vs -$0.12e; but widened out loss projections for the year from prior range.
<br />
(EAGL) EGL $0.27 EPS vs $0.17e.
<br />
(ELOS) Syneron $0.37 EPS vs $0.42e.
<br />
(ENTG) Entegris $0.13 EPS vs $0.11e.
<br />
(FLR) Fluor $1.00 EPS vs $0.66e; R$3.6B vs $3.35B(e); raised 2006 EPS from $2.80-3.10 up to $2.90-3.20.
<br />
(FNM) Fannie Mae delayed quarterly filing.
<br />
(FTEK) Fuel Tech $0.06/R$17.1M vs $0.08/$14M(e); EPS had charge in number.
<br />
(FTI) FMC Tech $0.47 EPS vs $0.45e.
<br />
(GAP) Great Atlantic & Pacific Tea -$0.95 EPS after charges vs -$0.41e.
<br />
(GEMS) Glenayre -$0.10 EPS vs -$0.03e; notified by Sprint-NexTel that they are no longer being offered as voicemail service provider.
<br />
(GIII) G-III Aparrel filed to sell 4M shares of common stock.
<br />
(GKIS) Gold Kist -$0.32 EPS vs -$0.35e.
<br />
(GIVN) Given Imaging -$0.11/R$20.3M vs -$0.11/$20.2M(e).
<br />
(GNTA) Genta's NDA accepted by the FDA for Genasense plus chemotherapy in relapsed and refractory CLL.
<br />
(HANS) Hansen Natural up 18% pre-market after higher earnings.
<br />
(HB) Hillenbrand $0.89 EPS vs $0.84e.
<br />
(HELE) Helen of Troy $0.30 EPS & R$134.5M vs $0.16/$126.75M(e); EPS was $0.21 with items.
<br />
(HSP) Hospira $0.62 EPS vs $0.48e.
<br />
(IDTI) Integrated Device Tech $0.15/R$167.5M vs $0.15/$165.2M(e).
<br />
(IFO) Infosonics $0.22 EPS vs $0.09e; stock up 9%.
<br />
(IT) Gartner registered 9.5M shares for selling shareholder.
<br />
(KG) King Pharma $0.44 EPS vs $0.37e.
<br />
(KMGB) KMG Chemicals filed to sell 3M shares of common stock.
<br />
(KOSP) Kos Pharma -$0.06/R$170.8M vs $0.03/$173.7M(e); announced up to 7M share buyback plan.
<br />
(KND) Kindred Healthcare sees revenues $46M lower on Medicare or Medicaid reimbursements.
<br />
(L) Liberty Media $0.02/R$1.98B vs $0.02/$2.00B(e).
<br />
(LAZ) Lazard $0.51 EPS vs $0.47e.
<br />
(MCD) McDonalds reported 4.1% s-s-s growth in US for April; up 6.5% worldwide.
<br />
(MIDD) Middleby $0.97 EPS vs $0.90e.
<br />
(MIVA) Miva -$0.03 EPS vs -$0.09e; guidance looks light; unsure if comparable.
<br />
(MRK) Merck is acquiring private GlycoFi for $400M cash.
<br />
(MRX)  Medicis Pharma received FDA approval for its New Drug Application of SOLODYN for
<br />
acne therapy
<br />
(NYM) Nymagic $0.85 EPS vs $0.65e.
<br />
(OMG) OM Group $0.62 EPS vs $0.62e.
<br />
(OPMR) Optimal Robotics $0.27 EPS vs $0.25e.
<br />
(OSIP) OSI Pharma -$0.31/R$116.4M vs -$0.12/$122.3M(e).
<br />
(PKS) Six Flags -$0.94 EPS vs -$1.20e.
<br />
(QGEN) Qiagen $0.13 EPS vs $0.12e.
<br />
(RBAK) Redback Networks filed to sell 11.3M shares of common stock.
<br />
(RNT) Aaron rents filed to sell 4M shares of common stock.
<br />
(RSAS) RSA Security filed to sell 1.99M shares of common stock for holders.
<br />
(SBAC) SBA Communications -$0.11/R$68.8M vs -$0.12/$67.25M(e); guides revenues higher.
<br />
(SLE) Sara Lee sells its Courtald's business unit.
<br />
(SRVY) Greenfield Online $0.03 EPS vs $0.00e.
<br />
(SWSI) Superior Wells $0.33 EPS vs $0.24e.
<br />
(SYGR) Synagro registered to sell 17.1M shares of common stock, only 2M are for the company.
<br />
(SYKE) Sykes Enterprises $0.15/R$131.1M EPS vs $0.10e/$127.9M(e).
<br />
(TGEN) Targeted Genetics authorized a 1-10 reverse split.
<br />
(THC) Tenet Healthcare $0.03/R$2.41B vs -$0.02/R$2.46B(e).
<br />
(TOA) Technical Olympic $0.89 EPS vs $0.82e.
<br />
(TRAK) Dealer Track $0.18 EPS vs $0.15e.
<br />
(TRFC) Traffic.com -$0.49/R$10.8M vs -$0.54/$10.78M(e).
<br />
(TWPG) Thomas Weisel filed to sell 4.5M shares of stock.
<br />
(USIH) USI Holdings $0.30 EPS vs $0.32e.
<br />
(V&TWX) Vivendi is reportedly creating a big budget fantasy/action film with Time's Warner Brothers unit based upon Vivendi's Blizzard unit hit game "World of Warcraft."
<br />
(VAS) Viasys $0.23 EPS vs $0.22e.
<br />
(VCLK) Valueclick $0.09/R$117M vs $0.11/$112M(e)revenue guidance looks in-line but EPS looks light.
<br />
(VTIV) Ventiv $0.34 EPS vs $0.30e.
<br />
(WGII) Washington Group $0.62 EPS vs $0.51e.
<br />
(WR) Westar Energy $0.30 EPS vs $0.25e.
<br />
(WWCA) WCA Waste $0.04 EPS vs $0.04e.
<br />
(ZIPR) Zip Realty -$0.04/R$19.2M vs -$0.16/$17.25M(e); guidance looks light.
</p><br/><a href='http://seekingalpha.com/article/10291-tuesday-pre-market-notes-by-stock-ticker?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Key IPOs This Week: Greenhill &amp; Co, Phillips-Van Heusen (BOOM, GHL, PVH)</title>
      <link>http://seekingalpha.com/article/10217-key-ipos-this-week-greenhill-co-phillips-van-heusen-boom-ghl-pvh?source=feed</link>
      <guid isPermaLink="false">10217</guid>
      <content>
        <![CDATA[<strong>Dynamic Materials (BOOM)</strong> should finally get this proposed secondary of 5.15+ million shares behind it.  Last month, the company disclosed that France's SNPE would be selling its 5.15+ million share stake so BOOM itself will not benefit from any of the proceeds.  Over the last year the shares are up well over 100%, but the shares are now off about 10% and have been down as much as about 17% since BOOM released earnings and disclosed this secondary offering.
</p>
<p><strong>Greenhill & Co (GHL) </strong>is expected to raise over $225M after its filing last week to sell 4.025 million shares, although these shares are being sold entirely by current and former directors and GHL will get none of the proceeds.  This stock is also up over 100% in the last year after a strong IPO since it is active in the M&A markets, and the company has actually recovered quite well off of its lows after having been down over 10%.
</p>]]>
      </content>
      <pubDate>Mon, 08 May 2006 10:58:14 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[<strong>Dynamic Materials (BOOM)</strong> should finally get this proposed secondary of 5.15+ million shares behind it.  Last month, the company disclosed that France's SNPE would be selling its 5.15+ million share stake so BOOM itself will not benefit from any of the proceeds.  Over the last year the shares are up well over 100%, but the shares are now off about 10% and have been down as much as about 17% since BOOM released earnings and disclosed this secondary offering.
</p>
<p><strong>Greenhill & Co (GHL) </strong>is expected to raise over $225M after its filing last week to sell 4.025 million shares, although these shares are being sold entirely by current and former directors and GHL will get none of the proceeds.  This stock is also up over 100% in the last year after a strong IPO since it is active in the M&A markets, and the company has actually recovered quite well off of its lows after having been down over 10%.
</p><br/><a href='http://seekingalpha.com/article/10217-key-ipos-this-week-greenhill-co-phillips-van-heusen-boom-ghl-pvh?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/boom">BOOM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ghl">GHL</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pvh">PVH</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>Monday Pre-Market Notes By Stock Ticker</title>
      <link>http://seekingalpha.com/article/10212-monday-pre-market-notes-by-stock-ticker?source=feed</link>
      <guid isPermaLink="false">10212</guid>
      <content>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong>
</p>
<p>S&P FAIR VALUE +$1.36.
</p>
<p>(AAPL) Apple has reportedly had an overseas ruling in its favor over the Beatles.
<br />
(ALY) Allis Chalmers filed to sell 4.7M shares of common stock.
<br />
(BRK/a) Berkshire Hathaway $1,501 vs $1,085 estimate; unsure if comparable on so many units; will pay $4B for an 80% stake in Iscar Metalworking and noted that it was interested in making acquisitions in Japan and elsewhere.
<br />
(DCGN) deCODE genetics discovered a marker for prostate cancer.
<br />
(EMMS) Emmis has a $15.25 CEO-management led buyout offer to buy the other 80+% of the company he doesn't own.
<br />
(FRZ) Reddy Ice filed to sell 4.59M shares.
<br />
(FSH) Fisher Scientific gets a 2 share to 1 stock buyout from Thermo Electron (TMO); although FSH is larger.
<br />
(GDW) Golden West Financial is merging with Wachovia in a $25B merger agreement, or $81.07 per share.
<br />
(HIV) Calbio named a new CEO.
<br />
(HNT) HealthNet $0.65 EPS vs $0.62e.
<br />
(INTC) Intel is rebranding to Core Duo name after Pentium, although this is pretty much already known.
<br />
(LPMA) Lipman Electronics $0.27 EPS vs $0.23e.
<br />
(MGRM) Monogram Bio in HIV pact with Pfizer; -$0.03/R$13.2M vs -0.03/$13.8M(e); stock up 18% pre-market.
<br />
(MHS) Medco will settle fraud allegations with the Justice Department according to the WSJ.
<br />
(MYOG) Myogen -$0.42 EPS vs -$0.36e.
<br />
(N) Inco Ltd. will get a merger proposal in Canada from tech Cominco for C$17.8B.
<br />
(NTLI) NTL is repoortedly cutting 6,000 jobs.
<br />
(PGIC) Progressive Gaming won approval for its live betting technology in Nevada.
<br />
(PLAB) Photronics announced a joint-venture with Micron (MU).
<br />
(RTN) Raytheon filed a $2B mixed securities shelf.
<br />
(SKYE)  SkyePharma and Kos Pharmaceuticals-KOSP sign license agreement for US marketing and distribution of SkyePharma's Flutiform.
<br />
(TWX) Time Warner hired Citigroup to explore its AOL Europe options according to the WSJ.
<br />
(WPSC) Wheeling-Pittsburgh Corporation and Companhia Siderurgica Nacional announced a pact for North America.
<br />
(YHOO) Yahoo is reportedly altering its advertising system after losing Microsoft.
<br />
(ZLC) Zale's placed its CFO on administrative leave.
</p>]]>
      </content>
      <pubDate>Mon, 08 May 2006 07:50:37 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[<p><strong>Via <a href="http://blog.newscontrast.com/">News Contrast</a>:</strong>
</p>
<p>S&P FAIR VALUE +$1.36.
</p>
<p>(AAPL) Apple has reportedly had an overseas ruling in its favor over the Beatles.
<br />
(ALY) Allis Chalmers filed to sell 4.7M shares of common stock.
<br />
(BRK/a) Berkshire Hathaway $1,501 vs $1,085 estimate; unsure if comparable on so many units; will pay $4B for an 80% stake in Iscar Metalworking and noted that it was interested in making acquisitions in Japan and elsewhere.
<br />
(DCGN) deCODE genetics discovered a marker for prostate cancer.
<br />
(EMMS) Emmis has a $15.25 CEO-management led buyout offer to buy the other 80+% of the company he doesn't own.
<br />
(FRZ) Reddy Ice filed to sell 4.59M shares.
<br />
(FSH) Fisher Scientific gets a 2 share to 1 stock buyout from Thermo Electron (TMO); although FSH is larger.
<br />
(GDW) Golden West Financial is merging with Wachovia in a $25B merger agreement, or $81.07 per share.
<br />
(HIV) Calbio named a new CEO.
<br />
(HNT) HealthNet $0.65 EPS vs $0.62e.
<br />
(INTC) Intel is rebranding to Core Duo name after Pentium, although this is pretty much already known.
<br />
(LPMA) Lipman Electronics $0.27 EPS vs $0.23e.
<br />
(MGRM) Monogram Bio in HIV pact with Pfizer; -$0.03/R$13.2M vs -0.03/$13.8M(e); stock up 18% pre-market.
<br />
(MHS) Medco will settle fraud allegations with the Justice Department according to the WSJ.
<br />
(MYOG) Myogen -$0.42 EPS vs -$0.36e.
<br />
(N) Inco Ltd. will get a merger proposal in Canada from tech Cominco for C$17.8B.
<br />
(NTLI) NTL is repoortedly cutting 6,000 jobs.
<br />
(PGIC) Progressive Gaming won approval for its live betting technology in Nevada.
<br />
(PLAB) Photronics announced a joint-venture with Micron (MU).
<br />
(RTN) Raytheon filed a $2B mixed securities shelf.
<br />
(SKYE)  SkyePharma and Kos Pharmaceuticals-KOSP sign license agreement for US marketing and distribution of SkyePharma's Flutiform.
<br />
(TWX) Time Warner hired Citigroup to explore its AOL Europe options according to the WSJ.
<br />
(WPSC) Wheeling-Pittsburgh Corporation and Companhia Siderurgica Nacional announced a pact for North America.
<br />
(YHOO) Yahoo is reportedly altering its advertising system after losing Microsoft.
<br />
(ZLC) Zale's placed its CFO on administrative leave.
</p><br/><a href='http://seekingalpha.com/article/10212-monday-pre-market-notes-by-stock-ticker?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>ARIAD's Victory Over Eli Lilly: The Impact (ARIA, LLY)</title>
      <link>http://seekingalpha.com/article/10116-ariad-s-victory-over-eli-lilly-the-impact-aria-lly?source=feed</link>
      <guid isPermaLink="false">10116</guid>
      <content>
        <![CDATA[ARIAD Pharmaceuticals (ARIA-NASDAQ) was briefly halted before re-opening above $7.00 after winning a lawsuit for patent infringement against Eli Lilly (LLY) for Evista® and Xigris®.  The damage award was $62.5M for past royalties of 2.3% of the sales, but the kicker is that ARIAD will get 2.3% royalties thru 2019 when its patent expires.  
<br />
<!--more-->
<br />
As far as how this will hit LLY, it is really more of an irritation than a killer for the company as LLY has a market cap of nearly $60 Billion with over $5 Billion in cash and equivalents.  ARIAD's market cap is only $341M so you would expect them to get a jump on this.  ARIAD is (or WAS before today) basically a non-revenue stage biopharma that posted merely $242,000 in revenues over its last quarter and it post losses of $14.99M after R&D and SG&A costs.  As of December 31, 2005 the company had liquid cash and equivalent assets of $81.5+M and it listed its total liabilities at $24.7M after having only $5.7M in long-term debt.
</p>
<p>LLY's sales on Evista for osteoporosis were $1.03B in 2005, but that is a worldwide number and it is approved in many countries.  The annual report shows US sales were $652.9M and foreign sales were $383.2M.  
</p>]]>
      </content>
      <pubDate>Fri, 05 May 2006 02:35:06 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[ARIAD Pharmaceuticals (ARIA-NASDAQ) was briefly halted before re-opening above $7.00 after winning a lawsuit for patent infringement against Eli Lilly (LLY) for Evista® and Xigris®.  The damage award was $62.5M for past royalties of 2.3% of the sales, but the kicker is that ARIAD will get 2.3% royalties thru 2019 when its patent expires.  
<br />
<!--more-->
<br />
As far as how this will hit LLY, it is really more of an irritation than a killer for the company as LLY has a market cap of nearly $60 Billion with over $5 Billion in cash and equivalents.  ARIAD's market cap is only $341M so you would expect them to get a jump on this.  ARIAD is (or WAS before today) basically a non-revenue stage biopharma that posted merely $242,000 in revenues over its last quarter and it post losses of $14.99M after R&D and SG&A costs.  As of December 31, 2005 the company had liquid cash and equivalent assets of $81.5+M and it listed its total liabilities at $24.7M after having only $5.7M in long-term debt.
</p>
<p>LLY's sales on Evista for osteoporosis were $1.03B in 2005, but that is a worldwide number and it is approved in many countries.  The annual report shows US sales were $652.9M and foreign sales were $383.2M.  
</p><br/><a href='http://seekingalpha.com/article/10116-ariad-s-victory-over-eli-lilly-the-impact-aria-lly?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/aria">ARIA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/lly">LLY</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
    <item>
      <title>IPO Alerts: DynCorp and Delek; When-Issued Alert: SprintNextel's Embarq (DCP, DK, EQ)</title>
      <link>http://seekingalpha.com/article/10079-ipo-alerts-dyncorp-and-delek-when-issued-alert-sprintnextel-s-embarq-dcp-dk-eq?source=feed</link>
      <guid isPermaLink="false">10079</guid>
      <content>
        <![CDATA[We had 2 key IPO's price for trading today: DynCorp and Delek.  DynCorp of course is the private defense and services contractor for the US governement, allies and corporations; and Delek is the refining and gas station company in the US.  We also have the when-issued trading today for Sprint Nextel's "Embarq" unit.

<p><img src='http://static.seekingalpha.com/wp-content/seekingalpha/images/dyncorplogo.gif' align="right" hspace="6" vspace="6" ' width="197" height="105" border='0' />DynCorp will trade under "DCP" on the NYSE and its 25M share IPO priced at $15.00, which is at the lower-end of the $15.00 to $17.00 expected pricing range.  DynCorp is being spun-off from the private equity group Veritas Capital, which it recently purchased from Computer Science Corp (CSC).
</p>
<p><img src="http://static.seekingalpha.com/wp-content/seekingalpha/images/deleklogo.gif" vspace="6" border="0" height="121" hspace="6" align="left" width="93" />Delek will trade under "DK" on the NYSE and its 10M share IPO priced at $16.00, at the high-end of the $14.00 to $16.00 range.  For some reason it hadn't gotten much attention up through last week (odd considering it has a refinery of its own), although this shaped up this week.  The company had 2005 revenues of $2.03 Billion and posted net income of $65M.  Lehman and Citigroup lead the offering with CSFB, Morgan Keegan, William Blair, HSBC, and the Israel Discount Bank of NY were co-managers.  Delek U.S. Holdings is being spun off by parent Delek Group, the Israeli oil conglomerate controlled by real estate mogul Yitzhak Tshuva.
</p>]]>
      </content>
      <pubDate>Thu, 04 May 2006 09:34:50 -0400</pubDate>
      <author>Jon Ogg</author>
      <description>
        <![CDATA[We had 2 key IPO's price for trading today: DynCorp and Delek.  DynCorp of course is the private defense and services contractor for the US governement, allies and corporations; and Delek is the refining and gas station company in the US.  We also have the when-issued trading today for Sprint Nextel's "Embarq" unit.

<p><img src='http://static.seekingalpha.com/wp-content/seekingalpha/images/dyncorplogo.gif' align="right" hspace="6" vspace="6" ' width="197" height="105" border='0' />DynCorp will trade under "DCP" on the NYSE and its 25M share IPO priced at $15.00, which is at the lower-end of the $15.00 to $17.00 expected pricing range.  DynCorp is being spun-off from the private equity group Veritas Capital, which it recently purchased from Computer Science Corp (CSC).
</p>
<p><img src="http://static.seekingalpha.com/wp-content/seekingalpha/images/deleklogo.gif" vspace="6" border="0" height="121" hspace="6" align="left" width="93" />Delek will trade under "DK" on the NYSE and its 10M share IPO priced at $16.00, at the high-end of the $14.00 to $16.00 range.  For some reason it hadn't gotten much attention up through last week (odd considering it has a refinery of its own), although this shaped up this week.  The company had 2005 revenues of $2.03 Billion and posted net income of $65M.  Lehman and Citigroup lead the offering with CSFB, Morgan Keegan, William Blair, HSBC, and the Israel Discount Bank of NY were co-managers.  Delek U.S. Holdings is being spun off by parent Delek Group, the Israeli oil conglomerate controlled by real estate mogul Yitzhak Tshuva.
</p><br/><a href='http://seekingalpha.com/article/10079-ipo-alerts-dyncorp-and-delek-when-issued-alert-sprintnextel-s-embarq-dcp-dk-eq?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/dcp">DCP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/dk">DK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/eq">EQ</category>
      <category type="author" link="http://seekingalpha.com/author/jon-ogg">Jon Ogg</category>
    </item>
  </channel>
</rss>
